- Citations, last 5 years
- 183.8k
- Works, last 5 years
- 38.6k
- h-index
- 821
- Scientists listed
- 3 447
- Grants since 2016
- 3 103
Grants received
2024–2029 · program · P50
UK ASCEND (Achieving Success in Community-Engaged research to elimiNate Disparities)
Darwin Lewis Conwell · University of Kentucky · funded by National Institutes of Health
2024–2028 · research · R01
Structure-Function-Aware Large Protein Language Models for Enhanced Biomedical Applications
Qing Shao · University of Kentucky · funded by National Institutes of Health
2024–2029 · research · R01
The Impact of Leukocyte-derived Cytokines on Ovulation in Humans
Yohan Choi · University of Kentucky · funded by National Institutes of Health
2024–2029 · research · R01
Harnessing engineered drug-free polymeric nanoformulations to reprogram innate immune cells for spinal trauma
Jonghyuck Park · University of Kentucky · funded by National Institutes of Health
2024–2026 · research · R36
Examining the Impact of the Criminal Legal System on Opioid Use Disorder Treatment and Recovery: A Socioecological Perspective
Marisa D. Booty · University of Kentucky · funded by National Institutes of Health
2024–2029 · research · R25
Quantitative Team Science (QuanTS) Program
Gina-Maria Pomann · University of Kentucky · funded by National Institutes of Health
2024–2027 · fellowship · F31
The myosin super-relaxed state and human dilated cardiomyopathy
Austin Wellette-Hunsucker · University of Kentucky · funded by National Institutes of Health
2024–2027 · research · R61
Using Exercise to Enhance Consolidation of Exposure-Based Therapeutic Learning in PTSD
Thomas G Adams · University of Kentucky · funded by National Institutes of Health
2024–2027 · research · R21
Novel Strategy to Augmenting Immunotherapy against Melanoma
Jin-Ming Yang · University of Kentucky · funded by National Institutes of Health
2024–2026 · fellowship · F99
Harnessing Extracellular Vesicles to Overcome Radiation Resistance in Pediatric Diffuse Midline Glioma
Viral Oza · University of Kentucky · funded by National Institutes of Health
2024–2030 · research · R01
Determining role of 14-3-3zeta in IL-17A signaling
Ritu Chakravarti · University of Kentucky · funded by National Institutes of Health
2024–2027 · research · R01
Influence of Orexin Antagonism on Motivation for Alcohol
William Walton Stoops · University of Kentucky · funded by National Institutes of Health
2024–2027 · research · R21
Combinatorial approach to restore breathing after spinal cord injury
Warren Joseph Alilain · University of Kentucky · funded by National Institutes of Health
2024–2027 · research · R00
The Role of SoxE Transcription Factors in Neural Crest Cell Specialization
Elizabeth Schock · University of Kentucky · funded by National Institutes of Health
2024–2026 · research · R61
Engaging Higher-Order Mechanisms of Psychopathology: A Parsimonious Approach to Precision Medicine
Shannon E Sauer-Zavala · University of Kentucky · funded by National Institutes of Health
2024–2026 · fellowship · F31
Randomized controlled trial of a single-session mechanism-focused intervention for suicidal thoughts and behaviors
Martina Fruhbauerova · University of Kentucky · funded by National Institutes of Health
2024–2027 · fellowship · F32
A multispecies system for elucidating proliferative control mechanisms during mammalian skin and musculoskeletal regeneration
Robyn S. Allen · University of Kentucky · funded by National Institutes of Health
2024–2027 · research · R21
Regulation of cocaine use by astrocyte voltage-gated channels
Pavel Ivanovich Ortinski · University of Kentucky · funded by National Institutes of Health
2024–2029 · research · R33
An innovative, trauma-informed approach for reducing overdose risk among women re-entering the community from prison
Kevin Knight · University of Kentucky · funded by National Institutes of Health
2024–2028 · research · R37
Mechanistic and structural insights into a new pro-metastatic collagen glucosyltransferase
Houfu Guo · University of Kentucky · funded by National Institutes of Health
2024–2026 · research · R21
Role of putative cytotoxins in Chlamydia infection
Kenneth A Fields · University of Kentucky · funded by National Institutes of Health
2024–2027 · research · R34
Optimizing Low Threshold TelePrEP Care in Syringe Service Programs for People who Inject Drugs in Appalachia
Hilary L Surratt · University of Kentucky · funded by National Institutes of Health
2024–2028 · research · R01
Targeting Endothelial Cell Mineralocorticoid Receptor Against Aortic Aneurysm in Females
Ming C Gong · University of Kentucky · funded by National Institutes of Health
2024–2026 · research · R21
R21-UKY East Palestine Train Derailment Health Tracking Study
Erin N Haynes · University of Kentucky · funded by National Institutes of Health
2024–2029 · career development · K25
Understand the mechanism of SARS-CoV-2 entry by single-molecule approaches
Prakash Shrestha · University of Kentucky · funded by National Institutes of Health
2024–2026 · research · R21
Evaluating causes for failure to thrive in a Noonan-like syndrome with loose anagen hair (NSLH) patients using NSLH vertebrate model
Emilia Galperin · University of Kentucky · funded by National Institutes of Health
2024–2028 · research · R01
Circadian Regulation of Cardiac Electrophysiology
Brian P Delisle · University of Kentucky · funded by National Institutes of Health
2024–2029 · research · R01
Optimizing PrEP Care Delivery through Adaptive Intervention Strategies for Underserved Rural People who Inject Drugs
Hilary L Surratt · University of Kentucky · funded by National Institutes of Health
2024–2030 · research · R01
Integrative Targeted Therapy for Melanoma
Jianxun Jim Song · University of Kentucky · funded by National Institutes of Health
2024–2026 · grant · G08
DASH-ing to Heart Health: Supporting Low-Income African American Women with an Interactive "Meals that Heal" Resource Book
Brandi Michelle White · University of Kentucky · funded by National Institutes of Health
2024–2029 · research · R01
Interactions between drug combinations and resistance acquisition risk for antimalarial ATP4 inhibitors
Joseph L. Derisi · University of Kentucky · funded by National Institutes of Health
2024–2029 · research · R01
Mechanisms of Sex-specific Metabolic Disruption Caused by Organophosphate Flame Retardant Exposure
Cetewayo Saif Rashid · University of Kentucky · funded by National Institutes of Health
2024–2026 · fellowship · F31
Bilirubin Catabolism induces Plasminogen-Activator Inhibitor 1 (PAI-1) worsening Metabolic Dysfunction
Zachary A Kipp · University of Kentucky · funded by National Institutes of Health
2024–2027 · research · R01
Role of Hypothalamic MC4R in Glucose Homeostasis via a Novel Neuroendocrine Circuit involving the Kidneys and Adrenal Glands
Kavaljit H Chhabra · University of Kentucky · funded by National Institutes of Health
2024–2028 · research · R01
Selective Glucocorticoid Receptor Antagonism in Alcohol Use Disorder: A Human Neuroscience Study
Mark T Fillmore · University of Kentucky · funded by National Institutes of Health
2024–2027 · research · R00
A pro-metastatic secretory program activated by epithelial-to-mesenchymal transition
Guan-Yu Xiao · University of Kentucky · funded by National Institutes of Health
2024–2025 · fellowship · F31
Role of Dynamic Signaling of NRG3-ErbB4 in the Prefrontal Cortex in Mediating Nicotine Withdrawal Phenotypes
Emily Prantzalos · University of Kentucky · funded by National Institutes of Health
2024–2028 · research · R01
Functional Interactions Between Lipoproteins and Protease Inhibitors in Atherosclerosis
Scott M Gordon · University of Kentucky · funded by National Institutes of Health
2024–2029 · research · R35
Cellular and Molecular Determinants of Post-Burn Myopathy
Allison M. Owen · University of Kentucky · funded by National Institutes of Health
2024–2027 · fellowship · F31
Uncovering the functional and mechanistic dysregulation of monocytes after abstinence and post-abstinence drinking
Madison Brooke Blanton · University of Kentucky · funded by National Institutes of Health